Your partner in Europe
  • Print page
  • Bookmark Page

Key Financial Data

Key Data

(m €)
2009 2010 2011 2012 2013
Net Sales 747.5
(100%)
728.1
(100%)
762.0
(100%)
828.3
(100%)
941.6
(100%)
Operating Income 162.2
(21.7%)
154.8
(21.3%)
163.5
(21.5%)
167.0
(20.2%)
195.4
(20.8%)
Net Income 110.6
(14.8%)
108.6
(14.9%)
116.4
(15.3%)
118.5
(14.3%)
133.7
(14.2%)

Net Sales

Net Sales graph

Sales by Business

Sales by Business pie-chart

Pharmaceuticals: Net Sales

Pharmaceutical Sales graph

Key P&L and Cash Flow

(m €)
2009 2010 2011 2012 2013
Net Sales 747.5 728.1 762.0 828.3 941.6
Gross profit
as % of Sales
511.9
68.5%
488.1
67.0%
502.1
65.9%
534.7
64.6%
614.3
65.2%
Operating Income
(EBIT) as % of Sales
162.2
21.7%
154.8
21.3%
163.5
21.5%
167.0
20.2%
195.4
20.8%
Pretax Income 152.7 151.0 160.0 160.3 180.8
Net Income 110.6 108.6 116.4 118.5 133.7
CASH FLOW 149.2 135.8 140.7 145.2 169.6

Balance Sheet Structure

Balance Sheet Structure chart

Per Share Data

2009 2010 2011 2012 2013
Earnings per share (EPS) 0.561 0.548 0.584 0.593 0.663
Shareholders'equity per share 2.575 2.896 2.982 2.297 3.463
Dividend for share 0.275 0.275 0.30 0.30 0.33
Last updated on:
07/03/14
08:49:28 CET
Delivered by Investis (opens in a new window)